Prognostic value of circulating C-reactive protein levels in patients with non-small cell lung cancer: A systematic review with meta-analysis | Zendy

Xinmin Yu | Zendy; Ying Jin | Zendy; Yan Sun | Zendy; Xun Shi | Zendy; Jun Zhao | Zendy; Lei Shi | Zendy

Open Access

Prognostic value of circulating C-reactive protein levels in patients with non-small cell lung cancer: A systematic review with meta-analysis

Author(s) -

Xinmin Yu,

Ying Jin,

Yan Sun,

Xun Shi,

Jun Zhao,

Lei Shi

Publication year - 2014

Publication title -

journal of cancer research and therapeutics

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.475

H-Index - 39

eISSN - 0973-1482

pISSN - 1998-4138

DOI - 10.4103/0973-1482.145854

Subject(s) - medicine , meta analysis , hazard ratio , lung cancer , confidence interval , oncology , subgroup analysis , c reactive protein , gastroenterology , inflammation

The clinical and prognostic significance of C-reactive protein (CRP) in nonsmall-cell lung cancer (NSCLC) remains inconsistent. To clarify a precise determinant of the clinical significance of CRP, we conducted a systematic review and meta-analysis to evaluate the overall risk of elevated CRP for survival in NSCLC.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research